Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 281

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1A
Chunk 281
---
about us or our business. If research analysts do not establish and maintain adequate research coverage or if one or more of the analysts
who covers us downgrades our Class A common stock or publishes inaccurate or unfavorable research about our business, the market price
for our Class A common stock would likely decline. If one or more of these analysts cease coverage of our Company or fail to publish
reports on us regularly, we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume
for our Class A common stock to decline.

We
are an “emerging growth company,” and the reduced reporting requirements applicable to emerging growth companies may make
our Class A common stock less attractive to investors.

We
are an “emerging growth company,” as defined in the JOBS Act. For as long as we continue to be an emerging growth company,
we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies, including exemption from compliance with the auditor attestation requirements of Section 404, reduced disclosure obligations
regarding executive compensation and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation
and stockholder approval of any golden parachute payments not previously approved. We will remain an emerging growth company until the
earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the closing of our initial public of, (b) in which
we have total annual gross revenue of at least $1.235 billion or (c) in which we are deemed to be a large accelerated filer, which means
the market value of our Class A common stock held by non-affiliates exceeds $700 million as of the end of our prior second fiscal quarter,
and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period.

-25-

In
addition, under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards until such time as those
standards apply to private companies. We may, in the future, elect not to avail ourselves of this exemption from new or revised accounting
standards and, therefore, may be subject to the same new or revised accounting standards as other public companies that are not emerging
growth companies.

We
cannot predict if investors will find our Class A common stock less attractive because we may rely on these exemptions. If some investors
find our